Related references
Note: Only part of the references are listed.PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis
Yu He et al.
CELL DEATH & DISEASE (2022)
Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer
Ju-Yi Hsu et al.
SCIENTIFIC REPORTS (2022)
Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors
Xin Cheng et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2022)
LLT1-CD161 Interaction in Cancer: Promises and Challenges
Veronique M. Braud et al.
FRONTIERS IN IMMUNOLOGY (2022)
The prognostic significance of serum interferon-gamma (IFN-γ) in hormonally dependent breast cancer
Natasa Todorovic-Rakovic et al.
CYTOKINE (2022)
Breast Cancer Statistics, 2022
Angela N. Giaquinto et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Triple negative breast cancer: Pitfalls and progress
Paola Zagami et al.
NPJ BREAST CANCER (2022)
Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52
Wen-liang Wang et al.
ACTA PHARMACOLOGICA SINICA (2021)
Metabolic protein phosphoglycerate kinase 1 confers lung cancer migration by directly binding HIV Tat specific factor 1
Yu-Chan Chang et al.
CELL DEATH DISCOVERY (2021)
Is oestrogen receptor-negative/progesterone receptor-positive (ER-/PR+) a real pathological entity?
Adedayo A. Onitilo et al.
ECANCERMEDICALSCIENCE (2021)
UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
Zi-Nan Lu et al.
CHINESE MEDICAL JOURNAL (2021)
The role of ferroptosis-related genes for overall survival prediction in breast cancer
Li-Yan Jin et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
Nathan D. Mathewson et al.
CELL (2021)
ER-/PR plus breast cancer: A distinct entity, which is morphologically and molecularly close to triple-negative breast cancer
Francoise Beltjens et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression
Fabiana Luond et al.
BRITISH JOURNAL OF CANCER (2021)
Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy
Dong-Hee Lee et al.
PHARMACEUTICALS (2021)
PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes
Rui Gou et al.
FRONTIERS IN ONCOLOGY (2021)
Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival
Y. Fan et al.
ESMO OPEN (2021)
Immune checkpoint signaling and cancer immunotherapy
Xing He et al.
CELL RESEARCH (2020)
Identification of Candidate Genes Associated with Breast Cancer Prognosis
Yun-Hua Xu et al.
DNA AND CELL BIOLOGY (2020)
TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy
Joseph G. Skeate et al.
FRONTIERS IN IMMUNOLOGY (2020)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Saray Quintero-Fabian et al.
FRONTIERS IN ONCOLOGY (2019)
Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database
Ki-Tae Hwang et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
MAGE-A antigens as targets for cancer immunotherapy
Erik Schooten et al.
CANCER TREATMENT REVIEWS (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
High expression of COL10A1 is associated with poor prognosis in colorectal cancer
Haipeng Huang et al.
ONCOTARGETS AND THERAPY (2018)
Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
Jennifer Q. Zhang et al.
CANCER IMMUNOLOGY RESEARCH (2018)
ERα is a negative regulator of PD-L1 gene transcription in breast cancer
Lu Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition
Tingting Li et al.
CELL DEATH & DISEASE (2018)
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng et al.
GENES & DISEASES (2018)
Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors
Zane A. Gibbs et al.
TRENDS IN CANCER (2018)
Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort
Homero Goncalves et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2018)
PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer
Deyuan Fu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Introduction to checkpoint inhibitors and cancer immunotherapy INTRODUCTION
Arlene H. Sharpe
IMMUNOLOGICAL REVIEWS (2017)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways
Shengwei Liu et al.
ONCOTARGET (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
New knowledge of the mechanisms of sorafenib resistance in liver cancer
Yan-jing Zhu et al.
ACTA PHARMACOLOGICA SINICA (2017)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
Hye Ryun Kim et al.
SCIENTIFIC REPORTS (2016)
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy
Aleix Prat et al.
BMC MEDICINE (2015)
The MAGE protein family and cancer
Jenny L. Weon et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Oncogenic cancer/testis antigens: prime candidates for immunotherapy
Morten F. Gjerstorff et al.
ONCOTARGET (2015)
Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis
Fanghui Ren et al.
PLOS ONE (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas
Jillian Cathcart et al.
GENES & DISEASES (2015)
Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer
P-P Wong et al.
ONCOGENE (2014)
MUC1: a multifaceted oncoprotein with a key role in cancer progression
Sritama Nath et al.
TRENDS IN MOLECULAR MEDICINE (2014)
The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
S. Muenst et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
D. W. Kufe
ONCOGENE (2013)
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Marco M. Hefti et al.
BREAST CANCER RESEARCH (2013)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms
Fran Supek et al.
PLOS ONE (2011)
Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours
S. M. Tovey et al.
BRITISH JOURNAL OF CANCER (2009)
Mucins in cancer: function, prognosis and therapy
Donald W. Kufe
NATURE REVIEWS CANCER (2009)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
